Malaria is common in areas such as Africa, South America, and Southern Asia. This medicine is not effective against all strains of malaria. What is the drug plaquenil used for Does plaquenil lower immune system What if plaquenil doesn't work for lupus Hydroxychloroquine HCQ We are testing the drug hydroxychloroquine HCQ to see if it can delay or prevent early stage T1D stage 1 from progressing to abnormal glucose tolerance stage 2 and ultimately prevent clinical diagnosis stage 3. HCQ is already used to reduce symptoms and progression of other autoimmune diseases. We aimed to compare the efficacy of methotrexate and hydroxychloroquine on refractory lichen planopilaris. Methods In a randomized clinical trial, 29 patients were randomly allocated to receive either 15 mg methotrexate/week or 200 mg hydroxychloroquine twice a day for 6 months. Clinical trials are research studies that involve people. The clinical trials on this list are studying Hydroxychloroquine. All trials on the list are supported by NCI. NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. Taking hydroxychloroquine long-term or at high doses may cause irreversible damage to the retina of your eye. Hydroxychloroquine is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. Hydroxychloroquine trial net Prevention Studies TRIALNET Type 1 Diabetes TrialNet, Clinical efficacy and safety of. - Hydroxychloroquine vs hydroxychlorPlaquenil altitude sicknessHydroxychloroquine cream side effects This trial is looking at adding a drug called hydroxychloroquine to treatment for chronic myeloid leukaemia that has already responded well to imatinib. Doctors often treat chronic myeloid leukaemia CML with a type of biological therapy called imatinib also known as Glivec. Many people respond well to imatinib. A trial of hydroxychloroquine with imatinib for chronic myeloid.. Clinical Trials Using Hydroxychloroquine - National Cancer.. NIDDK TrialNet Pathway To Prevention formerly Natural.. This study is testing a medication, called hydroxychloroquine HCQ to assess safety and effectiveness to prevent individuals at risk of type 1 diabetes T1D from progressing to type 1 diabetes. HCQ is approved by the U. S. Food and Drug Administration as a treatment for malaria, lupus, and rheumatoid arthritis. The results of this randomized clinical trial of hydroxychloroquine in systemic lupus erythematosus demonstrate that the discontinuation of treatment with this drug in patients with quiescent. For patients taking hydroxychloroquine to prevent malaria Your doctor may want you to start taking this medicine 1 to 2 weeks before you travel to an area where there is a chance of getting malaria. This will help you to see how you react to the medicine.